This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Magellan Launches Total Drug SolutionsSM Offering Complete Drug Management

Magellan Pharmacy Solutions, a subsidiary of Magellan Health Services Inc. (NASDAQ: MGLN), announced today the launch of Total Drug Solutions SM, a revolutionary integrated approach to managing all drugs – oral, injectable and infusible – to improve the quality and safety of care while lowering costs for consumers and health plans.

“Historically, patients have received standard medications and specialty drugs in a disconnected and uncoordinated fashion. This lack of integration presents safety risks, decreases therapeutic effectiveness and unnecessarily increases costs,” said Tina Blasi, president of Magellan Pharmacy Solutions.

“Payers have managed traditional pharmaceutical costs to a flat trend. However, specialty drug spending has increased dramatically . With recent advances in pharmaceutical technology, patients and payers need better support to coordinate treatment, manage costs and ensure patients achieve the best outcomes.

Total Drug Solutions combines our strengths in both specialty and medical drug management with our experience in traditional pharmacy benefit solutions to provide a patient-centric, 360-degree approach to drug management. Our philosophy is to help patients receive the right drug in the right amount at the right place.”

Magellan has launched a new website,, where health plans, employers and government agencies can learn more about the Total Drug Solutions suite of services. Evidence-based drug utilization tools ensure that coverage decisions are consistently applied across both medical and pharmacy benefits, reducing the variability of care. Magellan has enhanced its proprietary web-based utilization management system to empower providers with evidence-based information and decision support for all drugs.

“Our customers recognize that the true value comes in incorporating our specialty and medical pharmacy experience into these integrated, comprehensive services,” said Blasi.

“We combine this ‘total drug’ approach with a deep understanding of the most dynamic, and most difficult to manage, components of drug benefit management, such as utilization management in the physician practice and site-of-service management. This unrivaled breadth of experience and expertise will allow us to customize solutions to meet the changing needs of our customers.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs